NARI

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Inari Medical Inc

Inari Medical, Inc. is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Inari has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The company purpose-built its products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE: deep vein thrombosis and pulmonary embolism. The ClotTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium.
CEO
Employees
456
Headquarters

News

Inari Medical Stock Gained 21% on Thursday - Here''s Why It Soared
Aug 03, 2023 20:09pm

Inari Medical Inc (NASDAQ: NARI ) shares gained on Thursday after the company reported Q2 revenues of $119.0 million, up 28.3% Y/Y, beating the consensus of $116.28 million . The increase over the prior year quarter was driven primarily by global commercial expansion, increased adoption of our procedures, and introduction of new products. The company reported Q2 EPS of $0.04, a turnaround from an EPS … Full story available on Benzinga.com


Source:Benzinga
Why Shares of Inari Medical Are Up Thursday
Aug 03, 2023 18:26pm

The company announced second-quarter earnings.


Source:The Motley Fool
Inari Medical, Inc. (NARI) Q2 2023 Earnings Call Transcript
Aug 03, 2023 02:10am

Inari Medical, Inc. (NASDAQ:NASDAQ:NARI) Q2 2023 Earnings Call Transcript August 2, 2023 4:30 PM ETCompany ParticipantsJohn Hsu - Vice President of Investor RelationsDrew Hykes - President…


Source:Seeking Alpha
Inari Medical GAAP EPS of $0.04 beats by $0.16, revenue of $119M beats by $2.28M
Aug 02, 2023 20:25pm

Inari Medical press release (NARI): Q2 GAAP EPS of $0.04 beats by $0.16.Revenue of $119M (+28.4% Y/Y) beats by $2.28M.For the full year 2023, we are raising our revenue guidance to…


Source:Seeking Alpha
Inari Medical Q2 2023 Earnings Preview
Aug 01, 2023 21:35pm

Inari Medical (NARI) is scheduled to announce Q2 earnings results on Wednesday, August 2nd, after market close.The consensus EPS Estimate is -$0.12 and the consensus Revenue Estimate…


Source:Seeking Alpha
Inari Medical: Approaching Interesting Levels
Jul 31, 2023 10:06am

Inari Medical shares have been lagging after seeing strong momentum post its IPO in 2020. Click here to see why NARI stock is a Hold.


Source:Seeking Alpha